Ginascol John F
- SEC CIK
- 0001778075
No open-market purchases or sales filed in the past year.
Current role at each company
- ABT Abbott LaboratoriesEXECUTIVE VICE PRESIDENTas of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ginascol John F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 (view filing) | Mar 1 | 1 day | Ginascol John FEXECUTIVE VICE PRESIDENT | SSaleCommon shares without par value | −943 | $100.70 | −$95.0K | −0.8%118.4K after | |
| Dec 15, 2022 (view filing) | Dec 13 | 2 days | Ginascol John FEXECUTIVE VICE PRESIDENT | SSaleCommon shares without par value | −11.0K | $112.32 | −$1.24M | −8.9%111.9K after | |
| Mar 2, 2022 (view filing) | Mar 1, 2021 | 366 daysLate | Ginascol John FEXECUTIVE VICE PRESIDENT | SSaleCommon shares without par value | −365 | $118.16 | −$43.1K | −0.3%124.7K after |